It provides a novel tool for elucidating the molecular pathogenesis of the transformation by Hoxa9/Meis1 and is suitable for phenotype-based small molecule screen to identify potential agents for the treatment of AML. Here, MEIS1 is linked to acute myeloid leukemia.